Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -46.95% is in line with its 3-year average of -50.00%, near the high end of its 3-year range (-81.19%–-35.21%).
As of the fiscal period ended Tuesday, March 31, 2026. 1.96% above its 12-month average of -47.89%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
-46.95%
EBITDA MARGIN AVG TTM
-47.89%
EBITDA MARGIN AVG 3Y
-47.40%
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+1.96%
CURRENT VS 3Y AVG
+0.95%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Shoulder Innovations, Inc.
Market Cap
$468.68M
EBITDA Margin
-46.95%
TTM Avg
-47.89%
3Y Avg
-47.40%
5Y Avg
N/A
Market Cap
$15.31M
EBITDA Margin
-114.42%
TTM Avg
-123.66%
3Y Avg
-106.79%
5Y Avg
-92.91%
Market Cap
$1.26B
EBITDA Margin
3.96%
TTM Avg
-13.21%
3Y Avg
-146.19%
5Y Avg
-104.68%
Market Cap
$2.64B
EBITDA Margin
22.42%
TTM Avg
17.70%
3Y Avg
-0.76%
5Y Avg
-37.34%
Market Cap
$7.06B
EBITDA Margin
6.82%
TTM Avg
6.08%
3Y Avg
-0.44%
5Y Avg
-8.67%
Market Cap
$7.81B
EBITDA Margin
-3.14%
TTM Avg
-1.08%
3Y Avg
-5.02%
5Y Avg
-19.32%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $468.68M | -46.95% | -47.89% | -47.40% | N/A |
| NRC Health (NRC)vs › | $440.37M | 21.99% | 25.40% | 28.98% | 31.97% |
| 23andMe Holding Co. (ME)vs › | $15.31M | -114.42% | -123.66% | -106.79% | -92.91% |
| Teladoc Health, Inc. (TDOC)vs › | $1.26B | 3.96% | -13.21% | -146.19% | -104.68% |
| TransMedics Group, Inc. (TMDX)vs › | $2.64B | 22.42% | 17.70% | -0.76% | -37.34% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.76B | 16.41% | 1.22% | -1.65% | 4.31% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.06B | 6.82% | 6.08% | -0.44% | -8.67% |
| Oscar Health, Inc. (OSCR)vs › | $7.81B | -3.14% | -1.08% | -5.02% | -19.32% |
| Tempus AI, Inc. (TEM)vs › | $8.18B | -11.84% | -53.07% | -52.51% | -64.32% |
| Insulet Corp. (PODD)vs › | $9.23B | 21.67% | 20.24% | 16.36% | 15.66% |
Gross Margin
75.5%
EBITDA Margin
-46.9%
Operating Margin
-57.5%
Net Margin
-81.8%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | -46.95% |
| 2025-12-31 | -52.16% |
| 2025-09-30 | -57.83% |
| 2025-06-30 | -46.71% |
| 2025-03-31 | -35.79% |
| 2024-12-31 | -40.53% |
| 2024-09-30 | -52.08% |
| 2024-06-30 | -41.95% |
| 2024-03-31 | -38.39% |
| 2023-12-31 | -35.21% |
| 2023-09-30 | -81.19% |
| 2023-06-30 | -64.87% |
| 2023-03-31 | -56.30% |
